Literature DB >> 25745992

Systematic discovery of molecular probes targeting multiple non-orthosteric and spatially distinct sites in the botulinum neurotoxin subtype A (BoNT/A).

Saedeh Dadgar1, Wely B Floriano2.   

Abstract

The development of molecular probes targeting proteins has traditionally relied on labeling compounds already known to bind to the protein of interest. These known ligands bind to orthosteric or allosteric sites in their target protein as a way to control their activity. Binding pockets other than known orthosteric or allosteric sites may exist that are large enough to accommodate a ligand without significantly disrupting protein activity. Such sites may provide opportunities to discriminate between subtypes or other closely related proteins, since they are under less evolutionary pressure to be conserved. The Protein Scanning with Virtual Ligand Screening (PSVLS) approach was previously used to identify a novel inhibitor and a fluorescent probe against the catalytic site of the botulinum neurotoxin subtype A (BoNT/A). PSVLS screens compound databases against multiple sites within a target protein, and the results for all the sites probed against BoNT/A, not only the catalytic site, are available online. Here, we analyze the PSVLS data for multiple sites in order to identify molecular probes with affinity for binding pockets other than the catalytic site of BoNT/A. BoNT/A is a large protein with a light (LC) and a heavy (HC) chain that can be assayed separately. We used scintillation proximity assay (SPA) to test experimentally 5 probe candidates predicted computationally to have affinity for different non-orthosteric binding regions within the HC and LC, and one compound predicted not to have affinity for either domain. The binding profiles obtained experimentally confirmed the targeting of multiple and spatially distinct pockets within BoNT/A. Moreover, inhibition assay results indicate that some of these probes do not significantly interfere with the catalytic activity of BoNT/A.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Allosteric regulation; Biomarkers; Botulinum toxin; Holistic binding; Molecular docking; Molecular probes; Non-orthosteric binding

Mesh:

Substances:

Year:  2015        PMID: 25745992      PMCID: PMC4450111          DOI: 10.1016/j.mcp.2015.02.002

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  34 in total

Review 1.  International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology.

Authors:  Richard R Neubig; Michael Spedding; Terry Kenakin; Arthur Christopoulos
Journal:  Pharmacol Rev       Date:  2003-12       Impact factor: 25.468

2.  Initial purification of recombinant botulinum neurotoxin fragments for pharmaceutical production using hydrophobic charge induction chromatography.

Authors:  Gresham T Weatherly; Anne Bouvier; Debra D Lydiard; Jaymi Chapline; Ian Henderson; Jeffrey L Schrimsher; Scot R Shepard
Journal:  J Chromatogr A       Date:  2002-04-05       Impact factor: 4.759

Review 3.  Allosteric binding sites on cell-surface receptors: novel targets for drug discovery.

Authors:  Arthur Christopoulos
Journal:  Nat Rev Drug Discov       Date:  2002-03       Impact factor: 84.694

4.  Differential role of molten globule and protein folding in distinguishing unique features of botulinum neurotoxin.

Authors:  Raj Kumar; Roshan V Kukreja; Shuowei Cai; Bal R Singh
Journal:  Biochim Biophys Acta       Date:  2014-02-22

Review 5.  AGC protein kinases: from structural mechanism of regulation to allosteric drug development for the treatment of human diseases.

Authors:  José M Arencibia; Daniel Pastor-Flores; Angelika F Bauer; Jörg O Schulze; Ricardo M Biondi
Journal:  Biochim Biophys Acta       Date:  2013-03-21

6.  Structure-activity relationship study of indole-2-carboxamides identifies a potent allosteric modulator for the cannabinoid receptor 1 (CB1).

Authors:  Mariam M Mahmoud; Hamed I Ali; Kwang H Ahn; Aparna Damaraju; Sushma Samala; Venkata K Pulipati; Srikanth Kolluru; Debra A Kendall; Dai Lu
Journal:  J Med Chem       Date:  2013-10-07       Impact factor: 7.446

7.  Determinants of allosteric activation of yeast pyruvate kinase and identification of novel effectors using computational screening.

Authors:  C J Bond; M S Jurica; A Mesecar; B L Stoddard
Journal:  Biochemistry       Date:  2000-12-19       Impact factor: 3.162

8.  Chronic inflammation and elastin degradation in abdominal aortic aneurysm disease: an immunohistochemical and electron microscopic study.

Authors:  J Satta; A Laurila; P Pääkkö; K Haukipuro; R Sormunen; S Parkkila; T Juvonen
Journal:  Eur J Vasc Endovasc Surg       Date:  1998-04       Impact factor: 7.069

9.  HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases.

Authors:  Wely B Floriano; Nagarajan Vaidehi; Georgios Zamanakos; William A Goddard
Journal:  J Med Chem       Date:  2004-01-01       Impact factor: 7.446

10.  Procollagen III N-terminal propeptide and desmosine are released by matrix destruction in pulmonary tuberculosis.

Authors:  Jo Seddon; Victoria Kasprowicz; Naomi F Walker; Ho Ming Yuen; Henry Sunpath; Liku Tezera; Graeme Meintjes; Robert J Wilkinson; William R Bishai; Jon S Friedland; Paul T Elkington
Journal:  J Infect Dis       Date:  2013-08-06       Impact factor: 5.226

View more
  1 in total

1.  Creating and virtually screening databases of fluorescently-labelled compounds for the discovery of target-specific molecular probes.

Authors:  Rhiannon L Kamstra; Saedeh Dadgar; John Wigg; Morshed A Chowdhury; Christopher P Phenix; Wely B Floriano
Journal:  J Comput Aided Mol Des       Date:  2014-08-24       Impact factor: 3.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.